288 related articles for article (PubMed ID: 30890548)
1. Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma.
Idbaih A; Canney M; Belin L; Desseaux C; Vignot A; Bouchoux G; Asquier N; Law-Ye B; Leclercq D; Bissery A; De Rycke Y; Trosch C; Capelle L; Sanson M; Hoang-Xuan K; Dehais C; Houillier C; Laigle-Donadey F; Mathon B; André A; Lafon C; Chapelon JY; Delattre JY; Carpentier A
Clin Cancer Res; 2019 Jul; 25(13):3793-3801. PubMed ID: 30890548
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial of blood-brain barrier disruption by pulsed ultrasound.
Carpentier A; Canney M; Vignot A; Reina V; Beccaria K; Horodyckid C; Karachi C; Leclercq D; Lafon C; Chapelon JY; Capelle L; Cornu P; Sanson M; Hoang-Xuan K; Delattre JY; Idbaih A
Sci Transl Med; 2016 Jun; 8(343):343re2. PubMed ID: 27306666
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
[TBL] [Abstract][Full Text] [Related]
4. Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Sonabend AM; Gould A; Amidei C; Ward R; Schmidt KA; Zhang DY; Gomez C; Bebawy JF; Liu BP; Bouchoux G; Desseaux C; Helenowski IB; Lukas RV; Dixit K; Kumthekar P; Arrieta VA; Lesniak MS; Carpentier A; Zhang H; Muzzio M; Canney M; Stupp R
Lancet Oncol; 2023 May; 24(5):509-522. PubMed ID: 37142373
[TBL] [Abstract][Full Text] [Related]
5. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
6. Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.
Carpentier A; Stupp R; Sonabend AM; Dufour H; Chinot O; Mathon B; Ducray F; Guyotat J; Baize N; Menei P; de Groot J; Weinberg JS; Liu BP; Guemas E; Desseaux C; Schmitt C; Bouchoux G; Canney M; Idbaih A
Nat Commun; 2024 Feb; 15(1):1650. PubMed ID: 38396134
[TBL] [Abstract][Full Text] [Related]
7. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
Horodyckid C; Canney M; Vignot A; Boisgard R; Drier A; Huberfeld G; François C; Prigent A; Santin MD; Adam C; Willer JC; Lafon C; Chapelon JY; Carpentier A
J Neurosurg; 2017 Apr; 126(4):1351-1361. PubMed ID: 27285538
[TBL] [Abstract][Full Text] [Related]
8. Opening of the blood-brain barrier with an unfocused ultrasound device in rabbits.
Beccaria K; Canney M; Goldwirt L; Fernandez C; Adam C; Piquet J; Autret G; Clément O; Lafon C; Chapelon JY; Carpentier A
J Neurosurg; 2013 Oct; 119(4):887-98. PubMed ID: 23790118
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.
Liu HL; Hua MY; Chen PY; Chu PC; Pan CH; Yang HW; Huang CY; Wang JJ; Yen TC; Wei KC
Radiology; 2010 May; 255(2):415-25. PubMed ID: 20413754
[TBL] [Abstract][Full Text] [Related]
10. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.
McDannold N; Vykhodtseva N; Raymond S; Jolesz FA; Hynynen K
Ultrasound Med Biol; 2005 Nov; 31(11):1527-37. PubMed ID: 16286030
[TBL] [Abstract][Full Text] [Related]
11. Safety Profile of Low-Intensity Pulsed Ultrasound-Induced Blood-Brain Barrier Opening in Non-epileptic Mice and in a Mouse Model of Mesial Temporal Lobe Epilepsy.
Mathon B; Navarro V; Lecas S; Roussel D; Charpier S; Carpentier A
Ultrasound Med Biol; 2023 May; 49(5):1327-1336. PubMed ID: 36878831
[TBL] [Abstract][Full Text] [Related]
12. Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
Sabbagh A; Beccaria K; Ling X; Marisetty A; Ott M; Caruso H; Barton E; Kong LY; Fang D; Latha K; Zhang DY; Wei J; DeGroot J; Curran MA; Rao G; Hu J; Desseaux C; Bouchoux G; Canney M; Carpentier A; Heimberger AB
Clin Cancer Res; 2021 Aug; 27(15):4325-4337. PubMed ID: 34031054
[TBL] [Abstract][Full Text] [Related]
13. Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.
Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2015 Apr; 204():60-9. PubMed ID: 25724272
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier.
Leuthardt EC; Duan C; Kim MJ; Campian JL; Kim AH; Miller-Thomas MM; Shimony JS; Tran DD
PLoS One; 2016; 11(2):e0148613. PubMed ID: 26910903
[TBL] [Abstract][Full Text] [Related]
15. Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model.
Ahmed MH; Hernández-Verdin I; Quissac E; Lemaire N; Guerin C; Guyonnet L; Zahr N; Mouton L; Santin M; Petiet A; Schmitt C; Bouchoux G; Canney M; Sanson M; Verreault M; Carpentier A; Idbaih A
Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839777
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors.
Beccaria K; Canney M; Bouchoux G; Desseaux C; Grill J; Heimberger AB; Carpentier A
Cancer Lett; 2020 Jun; 479():13-22. PubMed ID: 32112904
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
Lin YL; Wu MT; Yang FY
J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
[TBL] [Abstract][Full Text] [Related]
18. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models.
Kovacs Z; Werner B; Rassi A; Sass JO; Martin-Fiori E; Bernasconi M
J Control Release; 2014 Aug; 187():74-82. PubMed ID: 24878186
[TBL] [Abstract][Full Text] [Related]
19. The Effects of Oxygen on Ultrasound-Induced Blood-Brain Barrier Disruption in Mice.
McDannold N; Zhang Y; Vykhodtseva N
Ultrasound Med Biol; 2017 Feb; 43(2):469-475. PubMed ID: 27789044
[TBL] [Abstract][Full Text] [Related]
20. Focused ultrasound microbubble destruction-mediated changes in blood-brain barrier permeability assessed by contrast-enhanced magnetic resonance imaging.
Wang F; Cheng Y; Mei J; Song Y; Yang YQ; Liu Y; Wang Z
J Ultrasound Med; 2009 Nov; 28(11):1501-9. PubMed ID: 19854965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
